Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

274.00p
   
  • Change Today:
      14.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 213,759
  • Market Cap: £274.00m
  • RiskGrade: 125

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.
Registrars: Capita Registrars

Key Personnel

CEO: Frank Mathias
CFO: Stuart Paynter
Chairman and CEO: Roch Doliveux
Independent Non-Executive Director: Namrata P Patel
Independent Non-Executive Director: Heather Preston
Independent Non-Executive Director: Leone Patterson
Independent Non-Executive Director: Catherine Moukheibir
Senior Independent Director: Dame Kay Davies
Vice Chairman: Stuart Henderson
Non-Executive Dir: Peter Soelkner, Michael Hayden, Robert Ghenchev

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: techMARK, FTSE Small Cap, FTSE All-Share, FTSE techMARK Focus
Overseas Listings: BATSLON:OXBL
ISIN: GB00BDFBVT43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 274.00p
Change Today 14.00p
% Change 5.38 %
52 Week High 470.00
52 Week Low 166.80
Volume 213,759
Shares Issued 100.00m
Market Cap £274.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.85% below the market average22.85% below the market average22.85% below the market average22.85% below the market average22.85% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
34.14% below the market average34.14% below the market average34.14% below the market average34.14% below the market average34.14% below the market average
35.71% above the sector average35.71% above the sector average35.71% above the sector average35.71% above the sector average35.71% above the sector average
Income Not Available
Growth
52.13% below the market average52.13% below the market average52.13% below the market average52.13% below the market average52.13% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 30-Apr-2024

Time Volume / Share Price
13:00 765 @ 274.00p
12:54 31 @ 274.00p
12:53 7 @ 274.84p
12:51 100 @ 274.00p
12:51 904 @ 274.68p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page